Format

Send to

Choose Destination
See comment in PubMed Commons below
Cancer Res. 2011 Mar 1;71(5):1526-32. doi: 10.1158/0008-5472.CAN-10-3069. Epub 2011 Jan 6.

Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles.

Author information

1
Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia 30322, USA.

Abstract

The detection and characterization of circulating tumor cells (CTC) holds great promise for personalizing medicine and optimizing systemic therapy. However, low specificity, low sensitivity, and the time consuming nature of current approaches have impeded clinical adoption. Here we report a new method using surface-enhanced Raman spectroscopy (SERS) to directly measure targeted CTCs in the presence of white blood cells. SERS nanoparticles with epidermal growth factor peptide as a targeting ligand have successfully identified CTCs in the peripheral blood of 19 patients with squamous cell carcinoma of the head and neck (SCCHN), with a range of 1 to 720 CTCs per milliliter of whole blood. Our technique may provide an important new clinical tool for management of patients with SCCHN and other cancers.

PMID:
21212408
PMCID:
PMC3079317
DOI:
10.1158/0008-5472.CAN-10-3069
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center